AzTrials
AzTrials

Chronic Post-surgical PainCSAPG-37NCT05920382

Radiofrequency Ablation for the Treatment of Post-knee Arthroplasty Chronic Pain.

A study testing Radiofrequency ablation of peripheral nerves. in people with Chronic Post-surgical Pain and Chronic Post Operative Pain, run by Consorci Sanitari de l'Alt Penedès i Garraf at 1 site in Spain.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Knee osteoarthritis pain is one of the conditions commonly seen in general and specialized medicine. Knee arthroplasty is one of the most successful orthopedic surgeries for the treatment of this disease, significantly improving pain, disability, and the overall quality of life for patients who undergo it. Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
Radiofrequency ablation of peripheral nerves.
Type of treatment
Surgery or procedure
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
86 participants
Where
1 siteSpain
Study dates
25 Sep 2023to 1 Dec 2028
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Individuals who have undergone knee arthroplasty.
  • Chronic knee pain post-knee arthroplasty for at least 6 months after the procedure and less than 5 years.
  • Pain intensity on the numerical visual scale ≥ 5 out of 10 points.
  • Stable pain for the last 30 days.
  • The knee is the location with the highest intensity of pain, in the case of patients with multiple joint pains.

Who cannot join

  • Acute knee pain.
  • Psychiatric illness or dementia that may interfere with or hinder study assessments.
  • Diagnosis of fibromyalgia, chronic fatigue syndrome, or central sensitization syndrome.
  • Knee infiltration with corticosteroids in the past 30 days.
  • Changes in oral analgesic medication in the past 30 days.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

ITALO G PISANI, MD contact

+34649034623

italopisani1976@gmail.com

ALEJANDRO RODRIGUEZ, PHD contact

+34607214125

ARODRIGUEZ@CSAPG.CAT

Spain1 site, 1 recruiting
  • Consorci Sanitari Alt'Pènedes i Garraf

    Barcelona, Catalonia, 08810

    Italo Pisani, MD, +34 938180440, igpisani@csapg.cat

    Noemi Casaponsa, +34 93, recerca@csapg.cat

    Recruiting

Other trials in Spain

About this study

Official title: Radiofrequency Ablation for the Treatment of Post-knee Arthroplasty Chronic Pain. A Randomized Double-blind Study. A Novel Approach.

Knee osteoarthritis pain is one of the conditions commonly seen in general and specialized medicine. Knee arthroplasty is one of the most successful orthopedic surgeries for the treatment of this disease, significantly improving pain, disability, and the overall quality of life for patients who undergo it. However, there is a subgroup of individuals in whom the pain persists or even worsens. Radiofrequency has been introduced over 10 years ago as a neuroablative technique targeting the genicular nerves, which innervate the sensory terminals of the knee joint, for the treatment of chronic pain in that region before or after arthroplasty. However, the results have not been entirely consistent. Recent anatomical studies have demonstrated the presence of other sensory terminal branches of the femoral nerve, such as the infrapatellar branch of the saphenous nerve, medial vastus nerve, intermediate vastus nerve, and lateral vastus nerve, which could be useful targets for the treatment of post-knee arthroplasty pain. To date, no studies have been conducted to address post-knee arthroplasty pain through the application of thermal radiofrequency on the sensory branches of the knee from the femoral nerve (infrapatellar branch of the saphenous nerve, medial vastus nerve, intermediate vastus nerve, lateral vastus nerve). Therefore, The investigators aim to conduct a randomized double-blind clinical trial where The investigators will apply thermal radiofrequency on the sensory terminal branches of the femoral nerve in the knee, based on recent anatomical studies. The objective of the study is to determine if radiofrequency ablation of sensory nerves in the knee improves pain and disability in patients with post-knee arthroplasty chronic pain at the L'Alt Penedés-Garraf Health Consortium. Method: This is a randomized double-blind clinical trial with two arms. Two groups will be used, where one group will receive thermal radiofrequency of sensory nerves in the knee, and the other group will receive a placebo treatment. The hypothesis The investigators propose is that radiofrequency ablation will alleviate at least 50% of baseline pain and disability in at least 50% of the patients.

Read the detailed description

Degenerative knee osteoarthritis pain is one of the main reasons for consultation in general and specialized medicine. Its assessment and treatment impose a high cost on healthcare systems, accounting for 0.5% of Spain's gross domestic product. Given the magnitude of the disease and the disability it causes in affected individuals, multiple therapies have been proposed, ranging from pharmacological therapy with nonsteroidal anti-inflammatory drugs, opioids, antidepressants, capsaicin cream treatment, and physiotherapy, to intra-articular treatments with corticosteroids and viscosupplements like hyaluronic acid, platelet-rich plasma, etc. Knee arthroplasty is one of the most successful orthopedic surgeries in current medicine, significantly improving pain, disability, and the overall quality of life for patients who undergo it. However, postoperative pain following knee arthroplasty remains a challenging problem, with incidence rates of pain and disability after the procedure ranging from 48% to 34%, respectively, at 3 and 6 months post-surgery, with iatrogenic nerve injury being the most common cause. There are limited therapeutic alternatives available from this point onwards.

Since the first description of using radiofrequency for the treatment of intractable chronic pain, it has become not only a tool for pain management but also a cornerstone in pain units' treatment. The use of radiofrequency ablation for pain is based on the premise that the transmission of radiofrequency current near nociceptive pathways would interrupt the pain stimulus through the destruction of the nervous tissue. Thermal radiofrequency has been successfully used in the treatment of facetogenic low back pain, sacroiliac joint pain, and discogenic low back pain.

In the year 2011, the first study was conducted on radiofrequency of the sensory nerves of the knee, known as the genicular nerves, using femoral and tibial condyles as anatomical references and fluoroscopy as an imaging guide. Unfortunately, discrepancies in terminology and anatomical descriptions have led to confusion among interventional physicians. Other researchers have demonstrated discrepancies with the studies published in 2011, making it more difficult to standardize the technique of neuroablation of these nerves. More recently, other researchers demonstrated a specific anatomical-ultrasound correlation of sensory terminal branches of the femoral and sciatic nerves that innervate the knee. The involved nerves include the infrapatellar branch of the saphenous nerve, the nerve to the medial vastus muscle, the nerve to the intermediate vastus muscle, the nerve to the lateral vastus muscle, the anterior branch of the obturator nerve, the recurrent peroneal nerve, and the lateral retinacular nerve.

Study justification:

Post-knee arthroplasty pain remains an unresolved problem, with various techniques applied to different anatomical targets yielding inconsistent results. To date, no studies have addressed post-knee arthroplasty pain through the application of thermal radiofrequency on sensory branches of the femoral nerve, namely the infrapatellar branch of the saphenous nerve, nerve to the medial vastus muscle, nerve to the intermediate vastus muscle, and nerve to the lateral vastus muscle guided by ultrasound.

Therefore, The investigators propose to conduct a randomized double-blind clinical trial where The investigators will apply thermal radiofrequency on the sensory terminal branches of the knee from the femoral nerve, including the medial vastus nerve, lateral vastus nerve, intermediate vastus nerve, and infrapatellar branch of the saphenous nerve.

Hypothesis:

Patients who receive radiofrequency ablation would experience a percentage reduction of at least 50% in baseline pain and disability at 3 months, which The investigators consider a clinically significant effect.

Being tested
Radiofrequency ablation of peripheral nerves.
Medical subject headings
Pain, Postoperative

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Radiofrequency ablation of peripheral nerves.Procedure or surgery

    Also called Radiofrecuency arm, Sham arm

    Randomized double-blind clinical trial where we will apply thermal radiofrequency to the sensory terminal branches of the femoral nerve in the knee, including the vasto medial nerve, vasto lateral nerve, vasto intermedio nerves, and the infrapatellar branch of the saphenous nerve.

Study groups in NCT05920382
Study groupRoleWhat they receive
Radiofrequency armExperimentalAfter identifying the nerves to be treated via ultrasound and confirming with neurostimulation, 1 ml of 2% lidocaine will be administered, followed by radiofrequency ablation. The physical parameters used are as follows: 90 seconds, 80 degrees Celsius, with a 22g needle with an active tip of 10 mm.
Receives: Procedure: Radiofrequency ablation of peripheral nerves.
Control armSham comparatorIn the same manner as with the RF group, the nerves to be treated are identified via ultrasound and confirmed by neurostimulation. Subsequently, sham radiofrequency is performed for 90 seconds.
Receives: Procedure: Radiofrequency ablation of peripheral nerves.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change Pain and Disability measured by Western Ontario and McMaster Universities Arthritis Index, (WOMAC).

    Determine if radiofrequency ablation of the medial vastus nerve, infrapatellar branch of the saphenous nerve, intermediate vastus nerve, and lateral vastus nerve improves pain and disability at 3 months compared to baseline, as measured by WOMAC questionnaire, in patients with post-knee arthroplasty pain, compared to patients treated with placebo.

    The WOMAC test consists of several questions that address different aspects related to pain and functionality of the affected joint. These questions are divided into three main domains:

    Pain, Stiffness, Physical function The change in test scores will be evaluated throughout the study period, comparing them to the baseline.

    Measured: 3 month

Secondary outcomes (7)
  1. Changes in pain measured by the Numeric Rating Scale for pain. (NRS)

    Determine whether radiofrequency ablation of the sensory nerves in the knee under study improves pain at 3 months compared to baseline in patients with post-knee arthroplasty pain, compared to patients treated with placebo.

    It consists of a straight line or a series of numbers from 0 to 10, where 0 represents "no pain" and 10 represents "the worst pain imaginable." The change in test scores will be evaluated throughout the study period, comparing them to the baseline.

    Measured: 3 month

  2. Neuropathic pain measured by Neuropathic Pain questionnaire (DN4)

    Determine if radiofrequency ablation of the studied knee sensory nerves improves pain at 3 months compared to baseline in patients with neuropathic pain following knee arthroplasty, compared to patients treated with placebo.

    Measured: 3 month

  3. Depression and anxiety measured by Hospital Anxiety and Depression Scale (HADS)

    Measure levels of depression and anxiety in patients undergoing radiofrequency ablation and study their influence on the response to radiofrequency therapy of the studied knee sensory nerves. The scores on the HADS are interpreted as follows:

    Anxiety:

    0-7: Normal (no clinically significant anxiety) 8-10: Mild anxiety 11-14: Moderate anxiety 15-21: Severe anxiety

    Depression:

    0-7: Normal (no clinically significant depression) 8-10: Mild depression 11-14: Moderate depression 15-21: Severe depression

    Measured: 3 month

  4. Degree of satisfaction with the procedure performed measured by categorical satisfaction scale of our hospital's pain unit.

    Compare the level of satisfaction among patients undergoing radiofrequency ablation of the knee sensory nerves for the treatment of chronic post-knee arthroplasty pain.

    Not satisfied: The treatment provided no relief and worsened my pain. Slightly satisfied: The treatment had minimal results and my pain barely improved.

    Moderately satisfied: The treatment had moderate results and my pain improved to some extent.

    Quite satisfied: The treatment was effective and my pain improved significantly.

    Very satisfied: The treatment was highly effective and my pain completely disappeared.

    Measured: 3 month

  5. Safety from the applied treatment measured by number of adverse events associated with the technique.

    Determine the safety of radiofrequency ablation of the knee sensory nerves in terms of the number of adverse events associated with the technique.

    Measured: 3 month

  6. Duration (YEARS) of pain and treatment outcomes measured by Numeric Rating Scale for pain.

    Assess if the time measured in years since the last knee arthroplasty is related to the outcomes of the applied therapy, such as the 50% reduction in pain and disability measured by the visual numeric pain scale.

    Measured: 3 month

  7. Duration (YEARS) of pain and treatment outcomes measured by WOMAC questionnaire.

    Assess if the time measured in years since the last knee arthroplasty is related to the outcomes of the applied therapy, such as the 50% reduction in pain and disability measured by WOMAC questionnaire

    Measured: 3 month

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted27 Jun 2023
  2. Study start25 Sep 2023
  3. Primary completion1 Sep 2027 (estimated)
  4. Study completion1 Dec 2028 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
Randomized double-blind clinical trial with two arms: Radiofrequency Arm (RFA): Thermal radiofrequency will be applied to the sensory nerves of the knee, along with local anesthetic and corticosteroid infiltration. Control Arm (CA): Simulated radiofrequency will be applied to the sensory nerves of the knee, along with local anesthetic and corticosteroid infiltration.
Masking
Triple blind
Who is masked
Participant, Care provider, Outcomes assessor
Enrolment
86 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05920382
Sponsor's protocol ID
CSAPG-37
Acronym
CSAPG-37
Status last verified
Oct 2026
First submitted
30 May 2023
Last updated
30 Oct 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Pisani-Zambrano IG, Segur-Vilalta JM, Orduna-Valls J, Rodriguez-Molinero A. Radiofrequency ablation for the treatment of chronic pain after knee arthroplasty: protocol for a randomized, double-blind study. Trials. 2026 Mar 25;27(1):353. doi: 10.1186/s13063-026-09585-8.

    PubMed 41882766

Questions about this trial

What is this clinical trial studying?

A study testing Radiofrequency ablation of peripheral nerves. in people with Chronic Post-surgical Pain and Chronic Post Operative Pain, run by Consorci Sanitari de l'Alt Penedès i Garraf at 1 site in Spain.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 30 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Spain. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact ITALO G PISANI, MD (+34649034623, italopisani1976@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change Pain and Disability measured by Western Ontario and McMaster Universities Arthritis Index, (WOMAC). (time frame: 3 month). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05920382, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Oct 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in